Zobrazeno 1 - 10
of 25
pro vyhledávání: '"J I Geh"'
Publikováno v:
Colorectal Disease.
Autor:
Z. Zia, Homoyon Mehrzad, Mengshi Yuan, T. A. Pawade, Tahir Shah, J. I. Geh, Tessa Oelofse, Richard P. Steeds, O. Nolan, H. Singh, C. J. H. May, Stephen J. Rooney, Nicola C. Edwards, Daniel H. Palmer, John Ayuk
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 101:183-190
Carcinoid heart disease (NET-CHD) is associated with the development of symptom-limited exercise capacity and high rates of morbidity and mortality.This study sought to determine the survival, cardiac function, and functional class following surgery.
Autor:
Gareth Griffiths, Simon Gollins, Lisette Sheena Nixon, John Staffurth, R Roy, Stephen Falk, J I Geh, Jonathan Rees, Jane M Blazeby, Ruby Ray, N Bashir, Chris Nicholas Hurt, S. Mukherjee, Tom Crosby, David Cunningham, Tim Maughan, John Bridgewater
Publikováno v:
Rees, J R E, Hurt, C N, Gollins, S, Mukherjee, S, Maughan, T, Falk, S J, Staffurth, J, Ray, R, Bashir, N, Geh, J I, Cunningham, D, Roy, R, Bridgewater, J, Griffiths, G, Nixon, L S, Blazeby, J M & Crosby, T 2015, ' Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer ', British Journal of Cancer, vol. 113, no. 4, pp. 603-610 . https://doi.org/10.1038/bjc.2015.258
British Journal of Cancer
British Journal of Cancer
BACKGROUND:Limited data describe patient-reported outcomes (PROs) of localised oesophageal cancer treated with definitive chemoradiotherapy(CRT). The phase 2/3 SCOPE-1 trial assessed the effectiveness of CRT±cetuximab. The trial for the first time p
Autor:
Rubina Begum, Latha Kadalayil, Rob Glynne-Jones, Charles Lowdell, Jonathan A. Ledermann, David Sebag-Montefiore, Helen Meadows, Roger D James, Sandy Beare, J I Geh, Leslie Samuel, David Cunningham
Publikováno v:
Annals of Oncology. 25:1616-1622
Background: Squamous cell carcinoma of the anus (SCCA) is highly sensitive to chemoradiation (CRT) which achieves good loco-regional control and preserves anal function. However, some patients require permanent stoma formation either as a result of s
Autor:
H. Benghiat, J I Geh, Peter Nightingale, R.M. Irving, Garth Cruickshank, M. Tiffany, Andrew Hartley, G. Heyes, Paul Sanghera, David Spooner
Publikováno v:
Clinical Oncology. 26:309-315
Aims To evaluate non-auditory toxicity and local control after linear accelerator stereotactic radiosurgery (SRS) for the treatment of vestibular schwannomas. Materials and methods The institutional policy was to use SRS for radiologically progressin
Publikováno v:
Clinical Oncology. 20:176-183
Aims With the aim of improving locoregional control, the use of preoperative chemoradiotherapy (CRT) for rectal cancer has increased. A pathological complete response (pCR) is often used as a surrogate marker for the efficacy of different CRT schedul
Autor:
Simon P. Bach, M Steward, David Sebag-Montefiore, Doug Speake, B Levy, J I Geh, James Hill, C J Smart, Jonathan Robinson, S Korsgen
Publikováno v:
The British journal of surgery. 103(8)
Background Organ-preserving treatment for early-stage rectal cancer may avoid the substantial perioperative morbidity and functional sequelae associated with total mesorectal excision (TME). The initial results of an organ-preserving approach using p
Publikováno v:
The British Journal of Radiology. 78:934-938
Pathological complete response (pCR) has been used as a marker for the efficacy of pre-operative chemoradiotherapy (CRT) schedules in rectal cancer. To date there have been no randomized trials comparing CRT regimens in rectal cancer. Prospective pha
Autor:
Daniel H. Palmer, D. R. Peake, Nicholas D. James, J I Geh, David Spooner, Syed A. Hussain, Deborah D. Stocken, P. Riley
Publikováno v:
British Journal of Cancer
A randomised phase III trial of MVAC (methotrexate, vincristine, doxorubicin, cisplatin) vs gemcitabine and cisplatin (GC) (G 1000 mg m(-2) days 1, 8, and 15 plus C 70 mg m(-2) day 2, q 4 wks) indicated GC had similar efficacy and lower toxicity (JCO
Publikováno v:
Clinical Oncology. 15:233-236
Aims: The late toxicity of short-course preoperative radiotherapy (SCPRT) after total mesorectal excision (TME) in resectable rectal cancer has not been adequately documented. The acute toxicity in a series of 176 consecutive patients has been previo